Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulatory Post-Marketing Surveillance Study (Usage Results Study) of Kynteles Injection (Vedolizumab) for the Approved Indications in South Korea

NCT04799496 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04799496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulatory Post-Marketing Surveillance Study (Usage Results Study) of Kynteles Injection (Vedolizumab) for the Approved Indications in South Korea
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
June 10, 2020
Completion date
June 30, 2025
Enrollment
688 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative, crohn disease, inflammatory bowel diseases